EHA–EBMT European CAR T-Cell Meeting

Our live event feature page helps you keep up to date with the latest in MM, fresh from congresses, worldwide!

The MM Hub is happy to be providing live coverage from the EHA-EBMT European CAR T-Cell Meetings, which will be taking place in a virtual format on 10th –12th February 2022. Visit this event page during the congress to access our live social media coverage!

Save to your areas of interest

Filter by content:

  • Types

    • COVID-19
    • High-risk
    • Newly diagnosed multiple myeloma
    • Relapsed/refractory multiple myeloma
    • TP53

  • Therapeutics

    • ARI0002h
    • Auto-HSCT
    • BCMA CAR-T
    • CAR therapy
    • CD19 CAR-T
    • Cevostamab
    • Ciltacabtagene autoleucel
    • Elranatamab
    • Idecabtagene vicleucel
    • T-cell engagers
    • Talquetamab
    • Teclistamab

  • Congresses

    • ASH 2022
    • CAR-T 2020
    • CAR-T 2021
    • CAR-T 2022
    • CAR-T 2023
    • CAR-T 2024
    • CAR-T 2025
    • TCT 2024

  • Trials

    • CARTITUDE-1
    • CARTITUDE-2
    • CARTITUDE-4
    • KarMMa
    • KarMMa-2
    • KarMMa-3
    • LEGEND-2

  • Expert Opinions

    • Arnon Nagler
    • Ibrahim Yakoub-Agha
    • Joshua Hill
    • Maria Themeli
    • María-Victoria Mateos
    • Michel Delforge
    • Natacha Bolaños
    • Paola Neri
    • Sofie Terwel

  • Educational Resources

    • Diagnostic and treatment guidelines
    • Supportive care

Articles and Podcasts

7th European CAR T-cell Meeting congress coverage

Catch up with our live social media coverage of multiple myeloma from the 7th European CAR T-ce...
Feb 17, 2025

Integrating cilta-cel into earlier lines of therapy: Rationale and latest data from CARTITUDE-2 and CARTITUDE-4

Here we summarize the rationale and latest clinical trial data investigating the use of cilta-c...
Apr 1, 2024

What factors contribute to resistance to BCMA-targeted CAR T-cell therapies in multiple myeloma?

During the EHA-EBMT 6th European CAR T-cell Meeting, the Multiple Myeloma Hub spoke to Paola Ne...
Mar 28, 2024

Latest updates on idecabtagene vicleucel: Results from the KarMMa-2 and KarMMa-3 trials

We summarize the latest updates on idecabtagene vicleucel treatment for patients with R/R MM an...
Mar 8, 2023

CAR-T 2023

Catch up with our live Twitter coverage from the EBMT-EHA 5th European CAR T-cell Meeting 2023.
Feb 10, 2023

Access and future prospects of advanced immunotherapies for multiple myeloma in Europe

During the 4th European CAR T-cell Meeting, the Multiple Myeloma Hub was pleased to speak with ...
Mar 19, 2022

What supportive care is needed for patients receiving CAR T-cell therapy?

During the 4th European CAR T-cell Meeting, the MM Hub was pleased to speak with Natacha Bolaño...
Mar 10, 2022